PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study

• Published in: Europace (London, England) Vol. 20; no. 12; pp. 1929 - 1935
• Main Authors: Middeldorp, Melissa E, Pathak, Rajeev K, Meredith, Megan, Mehta, Abhinav B, Elliott, Adrian D, Mahajan, Rajiv, Twomey, Darragh, Gallagher, Celine, Hendriks, Jeroen M L, Linz, Dominik, McEvoy, R Doug, Abhayaratna, Walter P, Kalman, Jonathan M, Lau, Dennis H, Sanders, Prashanthan
• Format: Journal Article
• Language: English
• Published: England 01-12-2018
• Subjects: Ablation Techniques; Aged; Atrial Fibrillation - diagnosis; Atrial Fibrillation - etiology; Atrial Fibrillation - physiopathology; Atrial Fibrillation - therapy; Body Mass Index; Cardiac Pacing, Artificial; Disease Progression; Female; Humans; Male; Middle Aged; Obesity - complications; Obesity - diagnosis; Obesity - physiopathology; Obesity - therapy; Progression-Free Survival; Prospective Studies; Recurrence; Registries; Risk Assessment; Risk Factors; Time Factors; Weight Loss
• ISSN: 1099-5129; 1532-2092
• DOI: 10.1093/europace/euy117

Atrial fibrillation (AF) is a progressive disease. Obesity is associated with progression of AF. This study evaluates the impact of weight and risk factor management (RFM) on progression of the AF.
As described in the Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up (LEGACY) Study, of 1415 consecutive AF patients, 825 had body mass index ≥ 27 kg/m2 and were offered weight and RFM. After exclusion, 355 were included for analysis. Weight loss was categorized as: Group 1 (<3%), Group 2 (3-9%), and Group 3 (≥10%). Change in AF type was determined by clinical review and 7-day Holter yearly. Atrial fibrillation type was categorized as per the Heart Rhythm Society consensus. There were no differences in baseline characteristic or follow-up duration between groups (P = NS). In Group 1, 41% progressed from paroxysmal to persistent and 26% from persistent to paroxysmal or no AF. In Group 2, 32% progressed from paroxysmal to persistent and 49% reversed from persistent to paroxysmal or no AF. In Group 3, 3% progressed to persistent and 88% reversed from persistent to paroxysmal or no AF (P < 0.001). Increased weight loss was significantly associated with greater AF freedom: 45 (39%) in Group 1, 69 (67%) in Group 2, and 116 (86%) in Group 3 (P ≤ 0.001).
Obesity is associated with progression of the AF disease. This study demonstrates the dynamic relationship between weight/risk factors and AF. Weight-loss management and RFM reverses the type and natural progression of AF.